According to a recently released study, a common class of diabetes medications can put individuals diagnosed with COVID-19 at greater risk of fatal complications from the disease. Sodium-glucose co-transporter 2 inhibitors (SGLT2i), including Jardiance (empagliflozin) and Invokana (canagliflozin), help treat diabetes by making patients urinate out glucose. However, these drugs can also put people at […]learn more
For some health conditions, all it takes is a couple of weeks of medication or a surgical procedure to resolve the problem once and for all. Diabetes is not one of those conditions. Managing diabetes is a lifelong commitment that requires knowledge, vigilance, and proactive steps to prevent the many risks and complications that can […]learn more
Dogs bring us joy, comfort, and companionship. But according to a just-released study, dogs who have diabetes may also bring their owners a greater chance of developing the condition themselves. Published in the journal BMJ, the study followed 208,980 dog owners and 123,566 cat owners in Sweden for an average of six years. Researchers also […]learn more
*Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings when you suspect readings may be in accurate, or when you experience symptoms that may be due to high or low blood glucose.
Reference 1: Data on file. Abbott Diabetes Care. 2, FreeStyle Libre 14 day User’s Manual
Indications and Important Safety Information
FreeStyle Libre and FreeStyle Libre 14 day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing and detecting trends and tracking patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments in persons (age 18 and older) with diabetes. The systems are intended for single patient use and require a prescription.
CONTRAINDICATIONS: Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.
WARNINGS/LIMITATIONS: Do not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. The system does not have alarms unless the sensor is scanned, and the system contains small parts that may be dangerous if swallowed. The system is not approved for pregnant women, persons on dialysis, or critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one. Review all product information before use or contact Abbott Toll Free (855-632-8658) or visit www.freestylelibre.us for detailed indications for use and safety information.html. . FreeStyle, Libre, and related brand marks are trademarks of Abbott Diabetes Care Inc. in various jurisdictions. Other trademarks are the property of their respective owners. ©2018 Abbott. ADC-09691 vLO 10/18